Literature DB >> 33654961

In situ, Cell-free Protein Expression on Microarrays and Their Use for the Detection of Immune Responses.

Katrin Hufnagel1,2, Dennis Reininger1,3, Siu Wang Ng3, Nadine Gassert1,3, Juliane K Rohland1, Soroosh Shahryarhesami3, Andrea S Bauer3, Tim Waterboer1, Jörg D Hoheisel3.   

Abstract

Until recently, whole-proteome microarrays for comprehensive studies of protein interactions were mostly produced by individual cloning and cellular expression of very many open reading frames, followed by protein isolation and purification as well as array production. To overcome this cumbersome process, we have developed a method to generate microarrays representing entire proteomes by a combination of multiple spotting and on-chip, cell-free protein expression. Here, we describe the protocol for the production of bacterial protein microarrays. With slight adaptations, however, the procedure can be applied to the proteome of any organism. Expression constructs of each gene are generated by PCR on bacterial genomic DNA followed by a common secondary amplification that is adding relevant regulative elements to either end of the constructs. The unpurified PCR-products are spotted onto the microarray surface. Full-length proteins are directly expressed in situ in a cell-free manner and stay attached to the surface without further action. As an example of a typical application, we describe here the proteome-wide analysis of the immune response to a bacterial infectious agent by characterizing the binding profiles of the antibodies in patient sera.
Copyright © 2019 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Cell-free expression; Immunoprofiling; On-chip; Proteomics; Whole-proteome microarrays

Year:  2019        PMID: 33654961      PMCID: PMC7854046          DOI: 10.21769/BioProtoc.3152

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  7 in total

1.  Single step generation of protein arrays from DNA by cell-free expression and in situ immobilisation (PISA method).

Authors:  M He; M J Taussig
Journal:  Nucleic Acids Res       Date:  2001-08-01       Impact factor: 16.971

2.  Generation of high density protein microarrays by cell-free in situ expression of unpurified PCR products.

Authors:  Philipp Angenendt; Jürgen Kreutzberger; Jörn Glökler; Jörg D Hoheisel
Journal:  Mol Cell Proteomics       Date:  2006-07-05       Impact factor: 5.911

3.  Printing protein arrays from DNA arrays.

Authors:  Mingyue He; Oda Stoevesandt; Elizabeth A Palmer; Farid Khan; Olle Ericsson; Michael J Taussig
Journal:  Nat Methods       Date:  2008-01-20       Impact factor: 28.547

4.  The ORFeome Collaboration: a genome-scale human ORF-clone resource.

Authors: 
Journal:  Nat Methods       Date:  2016-03       Impact factor: 28.547

5.  Self-assembling protein microarrays.

Authors:  Niroshan Ramachandran; Eugenie Hainsworth; Bhupinder Bhullar; Samuel Eisenstein; Benjamin Rosen; Albert Y Lau; Johannes C Walter; Joshua LaBaer
Journal:  Science       Date:  2004-07-02       Impact factor: 47.728

6.  Personalised proteome analysis by means of protein microarrays made from individual patient samples.

Authors:  Smiths S Lueong; Cuixia Di; Jonas V Schaefer; Andreas Plückthun; Jörg D Hoheisel
Journal:  Sci Rep       Date:  2017-01-03       Impact factor: 4.379

7.  Immunoprofiling of Chlamydia trachomatis using whole-proteome microarrays generated by on-chip in situ expression.

Authors:  Katrin Hufnagel; Smiths Lueong; Martina Willhauck-Fleckenstein; Agnes Hotz-Wagenblatt; Beiping Miao; Andrea Bauer; Angelika Michel; Julia Butt; Michael Pawlita; Jörg D Hoheisel; Tim Waterboer
Journal:  Sci Rep       Date:  2018-05-14       Impact factor: 4.379

  7 in total
  1 in total

1.  Use of Autoreactive Antibodies in Blood of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMN) for Grade Distinction and Detection of Malignancy.

Authors:  Niall Brindl; Henning Boekhoff; Andrea S Bauer; Matthias M Gaida; Hien T Dang; Jörg Kaiser; Jörg D Hoheisel; Klaus Felix
Journal:  Cancers (Basel)       Date:  2022-07-22       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.